News

STAT15h
UnitedHealth stock tumbles as CEO resigns, 2025 outlook pulled
UnitedHealth Group CEO Andrew Witty abruptly stepped down from the health insurance and care conglomerate on Tuesday, citing ...
FDA Appointee Is a Notorious Drug Critic With a Lot to Prove
Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for pharmaceutical companies and ...
The BMJ20h
Trump watch: US drug pricing to be slashed, attorney who threatened journals is removed, and more
US president Donald Trump has announced an executive order aimed at reducing US prescription drug costs by 30-80%. The policy would align US drug prices with the lowest prices paid internationally and ...
FDA’s future in MAHA hands: How leadership is changing the agency’s trajectory
While Prasad’s views may not align with many of the FDA’s traditional policies, they do fit into a broader MAHA agenda of ...
21 analysts advised buy AstraZeneca shares in January – see what £10k invested then is worth now
Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering if that's been reciprocated. The post 21 analysts advised buy AstraZeneca ...